The growth of Mexican SMO, (IMIC) Instituto Mexicano de Investigación Clínica has been steady. The first private research organization located in Mexico City, has established numerous academic and research affiliations with prestigious universities and hospitals. IMIC is currently negotiating an agreement with the largest and most important Pediatric Hospital in Mexico City to establish and manage a new Research Center within the hospital. IMIC is also developing a new Phase I site in collaboration with the most prominent private medical school in Mexico.
IMIC is currently conducting 30 clinical trials for sixteen sponsors, in areas that include CNS, Respiratory Allergies, Nutrition, Osteoarthritis, Diabetes, Ophthalmology, Skin infections, G-I, Respiratory Infections, Cancer, Vaccines and HIV/AIDS.
IMIC's research personnel include eleven full-time study coordinators well trained in GCP and ICH. It also has fifty specialists in its Investigator database, all experienced and with a large pre-screened patient base. IMIC patient database includes over three thousand patients and covers a wide spectrum of common and uncommon ailments.
The Quality Assurance department of IMIC is fully integrated. Recent USA audits confirm the quality standards of clinical research at IMIC.